Matches in Wikidata for { <http://www.wikidata.org/entity/Q63590934> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- Q63590934 description "clinical trial" @default.
- Q63590934 description "ensayu clínicu" @default.
- Q63590934 description "klinisch onderzoek" @default.
- Q63590934 description "клінічне випробування" @default.
- Q63590934 name "Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant" @default.
- Q63590934 type Item @default.
- Q63590934 label "Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant" @default.
- Q63590934 prefLabel "Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant" @default.
- Q63590934 P1050 Q63590934-891267AA-EE8D-4375-A18A-57A276FF61C3 @default.
- Q63590934 P1132 Q63590934-1BAD235C-B374-4E43-A6FB-09FD7BB4F938 @default.
- Q63590934 P131 Q63590934-21EF8787-5A4B-49AE-B05C-5BAE7496B466 @default.
- Q63590934 P1476 Q63590934-353B2686-C917-4BA8-AEFD-F7A3A587926C @default.
- Q63590934 P17 Q63590934-836CFE90-C50A-4D45-8764-40CD87920BA0 @default.
- Q63590934 P17 Q63590934-B3E5B01A-911D-471C-A8A9-8869E153B7E0 @default.
- Q63590934 P2899 Q63590934-2C8ED6EF-5B54-41D4-838E-AE2F6C5C8C8B @default.
- Q63590934 P3098 Q63590934-A4531BCE-A8A0-4F88-8E62-F9C9792CBEF5 @default.
- Q63590934 P31 Q63590934-D0F2FFA6-D331-4197-B283-03B3CC2D0D3B @default.
- Q63590934 P4135 Q63590934-E5A3A3A7-397F-48D8-BD6D-5796D4EA4A6A @default.
- Q63590934 P4844 Q63590934-B7BE2D0E-5EF9-42E4-A71C-2417F8750C72 @default.
- Q63590934 P4844 Q63590934-E9C0607C-0988-49C8-94E5-0B21921DB55C @default.
- Q63590934 P580 Q63590934-87A6A44B-84F0-4AD2-B3EB-665BF7438480 @default.
- Q63590934 P582 Q63590934-0857693C-FBFA-4427-905C-79DF65D1F28A @default.
- Q63590934 P6099 Q63590934-F05D7923-4A76-4E47-98D2-0056D386684B @default.
- Q63590934 P6153 Q63590934-2281EC31-36E2-4C76-8E21-622F4263AA51 @default.
- Q63590934 P6153 Q63590934-32EEC6A0-24E3-4420-B9B0-C7EEE2FB1C3B @default.
- Q63590934 P6153 Q63590934-38769781-1752-4690-BA9E-6592C91FB5E0 @default.
- Q63590934 P6153 Q63590934-39F20DD1-9173-4262-B199-461263DC5B4A @default.
- Q63590934 P6153 Q63590934-3C12A18A-92A0-459B-8E85-A5625D3DC9B5 @default.
- Q63590934 P6153 Q63590934-4610B6DC-82B7-4E6A-913A-B7619B079CB9 @default.
- Q63590934 P6153 Q63590934-5534D676-4F64-41A5-A682-40CE6A1D9BB3 @default.
- Q63590934 P6153 Q63590934-68A15B80-7CAC-4E81-B742-0FC4DD2B12DA @default.
- Q63590934 P6153 Q63590934-6ACD7C9B-6474-44D6-9EC5-E7D7C4F75DCE @default.
- Q63590934 P6153 Q63590934-6DA94539-8E93-4BDE-A8CB-97082EBFB92D @default.
- Q63590934 P6153 Q63590934-73DB9B26-CF20-4AB7-B1AC-DDA7777736EC @default.
- Q63590934 P6153 Q63590934-73FD0E6B-D8DA-4507-8EC2-C7D16F4E279C @default.
- Q63590934 P6153 Q63590934-8937CE0F-1B16-48C0-8CAF-FCB7A14248E0 @default.
- Q63590934 P6153 Q63590934-A7EE18FD-E88D-4048-A49F-54A35CB96979 @default.
- Q63590934 P6153 Q63590934-C492CC3A-8BFD-4102-94AE-6A783F6F2C3B @default.
- Q63590934 P6153 Q63590934-CA08564A-EDD2-40B1-AB43-3A845D0EE1C2 @default.
- Q63590934 P6153 Q63590934-EA63EF2B-5BAE-475F-8F2C-CAF5B4FB9F6E @default.
- Q63590934 P6153 Q63590934-F7268707-59BE-49B0-A7D1-AC88EF8C59DC @default.
- Q63590934 P6153 Q63590934-FCD6FA14-DBA4-4B5A-9A6E-A13FAA418C81 @default.
- Q63590934 P6153 Q63590934-FDECDC16-F835-4588-A1D3-2E37DD39C549 @default.
- Q63590934 P8363 Q63590934-69380997-9454-4A17-9254-FBE6F224C1CD @default.
- Q63590934 P1050 Q29496 @default.
- Q63590934 P1132 "+450" @default.
- Q63590934 P131 Q1183 @default.
- Q63590934 P1476 "Impact of Cleansing With Chlorhexidine Gluconate (CHG) on Reducing Central Line Associated Bloodstream Infection (CLABSI) and Acquisition of Multi-drug Resistant Organisms (MDRO) in Children With Cancer or Those Receiving Allogeneic Hematopoietic Cell Transplantation (HCT)" @default.
- Q63590934 P17 Q16 @default.
- Q63590934 P17 Q30 @default.
- Q63590934 P2899 "+2" @default.
- Q63590934 P3098 "NCT01817075" @default.
- Q63590934 P31 Q30612 @default.
- Q63590934 P4135 "+21" @default.
- Q63590934 P4844 Q15646788 @default.
- Q63590934 P4844 Q15709152 @default.
- Q63590934 P580 "2013-11-04T00:00:00Z" @default.
- Q63590934 P582 "2019-03-31T00:00:00Z" @default.
- Q63590934 P6099 Q42824827 @default.
- Q63590934 P6153 Q1048851 @default.
- Q63590934 P6153 Q1061104 @default.
- Q63590934 P6153 Q1159198 @default.
- Q63590934 P6153 Q1164246 @default.
- Q63590934 P6153 Q193727 @default.
- Q63590934 P6153 Q282097 @default.
- Q63590934 P6153 Q29052 @default.
- Q63590934 P6153 Q2945735 @default.
- Q63590934 P6153 Q30254344 @default.
- Q63590934 P6153 Q392667 @default.
- Q63590934 P6153 Q4115972 @default.
- Q63590934 P6153 Q457281 @default.
- Q63590934 P6153 Q49112 @default.
- Q63590934 P6153 Q5098129 @default.
- Q63590934 P6153 Q5098193 @default.
- Q63590934 P6153 Q5161492 @default.
- Q63590934 P6153 Q5330270 @default.
- Q63590934 P6153 Q6859100 @default.
- Q63590934 P6153 Q7681712 @default.
- Q63590934 P6153 Q7972509 @default.
- Q63590934 P8363 Q78089383 @default.